[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Topical Pain Relief Market

April 2019 | 200 pages | ID: GAAB129D261EN
Bizwit Research & Consulting LLP

US$ 3,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Topical Pain Relief Market valued approximately USD 7.48 billion in 2017 is anticipated to grow with a healthy growth rate of more than 7.42% over the forecast period 2018-2025. The Topical Pain Relief Market is continuously growing in the global scenario at significant pace. Pain treatment involves usage of common analgesics or painkillers to reduce and treat body pain. Whenever, these analgesics are applied directly to the skin they are known as topical pain relief medications. These include topical administration of drugs such as nonsteroidal anti-inflammatory drugs, anesthetics, capsaicin, tricyclic antidepressants, ketamine, clonidine, opioids, and cannabinoids. Topical pain relief medications exert peripheral effects near the site of application and minimize the pain. Rise in cases of arthritis & other bone-related conditions, rising geriatric population, and increase in demand for topical pain relief by sports players are the substantial driving factors of the market during the forecast period. Moreover, emergence of online pharmacy and increasing demand from developing economies are the factor that likely to creating lucrative opportunity in the near future. In addition, Topical Pain relief starts medication more quickly which is also a major factor that impelling the market growth across the world. However, side effects caused by Topical Pain relief such as skin irritation, unpleasant odor and allergic reactions due to usage of pain relivers is one of the major factor that limiting the market growth of Topical Pain Relief during the forecast period.

The regional analysis of Global Topical Pain Relief Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to high awareness about the side effects caused by pain relivers, presence of large number of vendors of Topical Pain relief and increasing number of people suffering from schizophrenia in the region. Europe is estimated to grow at stable growth rate in the global Topical Pain Relief market over the upcoming years. Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 owing to growing concern towards health among people and rising prevalence chronic diseases such as cancer in the region.

The major market player included in this report are:
  • Johnson & Johnson
  • Novartis AG
  • GlaxoSmithKline Plc.
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sanofi S.A.
      • Tropical Bio Medics
  • AdvaCare Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Nestle S.A.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutic Class:
  • Non-Opioids
  • Opioids
By Type:
  • Prescription Pain Relief
  • Over-the-Counter (OTC) Pain Relief
By Formulation:
  • Cream
  • Gel
  • Spray
  • Patch
  • Others
By Distribution Channel:
  • Pharmacies & Drug Stores
  • E-Commerce
  • Retail & Grocery Stores
By Regions:
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World
Furthermore, years considered for the study are as follows:
  • Historical year – 2015, 2016
  • Base year – 2017
  • Forecast period – 2018 to 2025
Target Audience of the Global Topical Pain Relief Market in Market Study:
  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
  1.3.1. Topical Pain Relief Market, by Therapeutic Class, 2015-2025 (USD Billion)
  1.3.2. Topical Pain Relief Market, by Type, 2015-2025 (USD Billion)
  1.3.3. Topical Pain Relief Market, by Formulation, 2015-2025 (USD Billion)
  1.3.4. Topical Pain Relief Market, by Distribution Channel, 2015-2025 (USD Billion)
  1.3.5. Topical Pain Relief Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. TOPICAL PAIN RELIEF MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Formulation Evolution
  2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. TOPICAL PAIN RELIEF MARKET DYNAMICS

3.1. See Saw Analysis
  3.1.1. Market Drivers
  3.1.2. Market Challenges
  3.1.3. Market Opportunities

CHAPTER 4. TOPICAL PAIN RELIEF MARKET FORMULATION ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Buyers
  4.1.2. Bargaining Power of Suppliers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
  4.2.1. Political Scenario
  4.2.2. Economic Scenario
  4.2.3. Social Scenario
  4.2.4. Technological Scenario
4.3. Value Chain Analysis
  4.3.1. Supplier
  4.3.2. Manufacturers/Service Provider
  4.3.3. Distributors
  4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
  4.6.1. Raw Material Cost Analysis
  4.6.2. Manufacturing Cost Analysis
  4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion

CHAPTER 5. TOPICAL PAIN RELIEF MARKET, BY THERAPEUTIC CLASS

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Topical Pain Relief Market, Sub Segment Analysis
  5.4.1. Non-Opioids
    5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.4.2. Opioids
    5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. TOPICAL PAIN RELIEF MARKET, BY TYPE

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Key Market Players
6.4. Topical Pain Relief Market, Sub Segment Analysis
  6.4.1. Prescription Pain Relief
    6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.2. Over-the-Counter (OTC) Pain Relief
    6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. TOPICAL PAIN RELIEF MARKET, BY FORMULATION

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Key Market Players
7.4. Topical Pain Relief Market, Sub Segment Analysis
  7.4.1. Cream
    7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.2. Gel
    7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.3. Spray
    7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.4. Patch
    7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.5. Others
    7.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. TOPICAL PAIN RELIEF MARKET, BY DISTRIBUTION CHANNEL

8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Key Market Players
8.4. Topical Pain Relief Market, Sub Segment Analysis
  8.4.1. Pharmacies & Drug Stores
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.2. E-Commerce
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.3. Retail & Grocery Stores
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. TOPICAL PAIN RELIEF MARKET, BY REGIONAL ANALYSIS

9.1. Topical Pain Relief Market, Regional Market Snapshot (2015-2025)
9.2. North America Topical Pain Relief Market Snapshot
  9.2.1. U.S.
    9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.2.2. Canada
    9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Topical Pain Relief Market Snapshot
  9.3.1. U.K.
    9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.2. Germany
    9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.3. France
    9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.4. Rest of Europe
    9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Topical Pain Relief Market Snapshot
  9.4.1. China
    9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.2. India
    9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.3. Japan
    9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.4. Rest of Asia Pacific
    9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Topical Pain Relief Market Snapshot
  9.5.1. Brazil
    9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.5.2. Mexico
    9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
  9.6.1. South America
    9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.6.2. Middle East and Africa
    9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.2. Therapeutic Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.4. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.5. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
  10.3.1. Johnson & Johnson
    10.3.1.1. Overview
    10.3.1.2. Financial (Subject to Data Availability)
    10.3.1.3. Summary
    10.3.1.4. Recent Developments
  10.3.2. Novartis AG
  10.3.3. GlaxoSmithKline Plc.
  10.3.4. Pfizer Inc.
  10.3.5. Reckitt Benckiser Group Plc
  10.3.6. Sanofi S.A.
  10.3.7. Tropical Bio Medics
  10.3.8. AdvaCare Pharma
  10.3.9. Sun Pharmaceutical Industries Ltd.
  10.3.10. Nestle S.A.

CHAPTER 11. RESEARCH PROCESS

11.1. Research Process
  11.1.1. Data Mining
  11.1.2. Analysis
  11.1.3. Market Estimation
  11.1.4. Validation
  11.1.5. Publishing
  11.1.6. Research Assumption


More Publications